Novel Non-opioid Post-surgical Pain Treatment in Females

PHASE2WithdrawnINTERVENTIONAL
0
Timeline

Start Date

November 1, 2021

Primary Completion Date

December 30, 2023

Study Completion Date

January 30, 2024

Conditions
Acute PainBunionectomyToe Fusion
Interventions
DRUG

Carbidopa-Levodopa (100mg/25mg):

Participants will take 2 capsules (one containing naproxen, and the other containing either placebo or carbidopa/levodopa) 3 times per day (TID) for 5 days, the first dose is given right after the surgical procedure.

DRUG

Naproxen

Participants will take 2 capsules (one containing naproxen, and the other containing either placebo or carbidopa/levodopa) 3 times per day (TID) for 5 days, the first dose is given right after the surgical procedure.

Trial Locations (1)

60611

Northwestern University Feinberg School of Medicine, Chicago

Sponsors
All Listed Sponsors
collaborator

Northwestern Medical Group

OTHER

collaborator

National Institutes of Health (NIH)

NIH

lead

Northwestern University

OTHER

NCT05087914 - Novel Non-opioid Post-surgical Pain Treatment in Females | Biotech Hunter | Biotech Hunter